- Sections
- C - Chimiemétallurgie
- C07H - Sucresleurs dérivésnucléosidesnucléotidesacides nucléiques
- C07H 19/12 - Radicaux triazine
Détention brevets de la classe C07H 19/12
Brevets de cette classe: 127
Historique des publications depuis 10 ans
|
12
|
6
|
11
|
5
|
7
|
9
|
12
|
5
|
3
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Idorsia Pharmaceuticals Ltd. | 343 |
6 |
| ScinoPharm Taiwan, Ltd. | 129 |
5 |
| Ohara Pharmaceutical Co., Ltd. | 38 |
5 |
| Merck Sharp & Dohme LLC | 3751 |
5 |
| Celgene Corporation | 1392 |
4 |
| Cilag AG | 12 |
4 |
| Gilead Sciences, Inc. | 2134 |
4 |
| Rome Therapeutics, Inc. | 32 |
4 |
| Emory University | 1685 |
3 |
| Epigenetics Pharma LLC | 6 |
3 |
| Southern Research Institute | 208 |
3 |
| Janssen Biopharma, Inc. | 36 |
3 |
| Massachusetts Institute of Technology | 10181 |
2 |
| Board of Regents, The University of Texas System | 5989 |
2 |
| The Johns Hopkins University | 5772 |
2 |
| Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 46 |
2 |
| Oregon Health & Science University | 761 |
2 |
| The Scripps Research Institute | 1343 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2942 |
2 |
| Universite de Montreal | 342 |
2 |
| Autres propriétaires | 62 |